PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Trump Meets With Two US FDA Commissioner Candidates.pdf


Preview of PDF document trump-meets-with-two-us-fda-commissioner-candidates.pdf

Page 1 2 3

Text preview


Trump Meets With Two US FDA
Commissioner Candidates; Third Still
Lurking
12 Jan 2017
NEWS

Derrick Gingery @dgingery derrick.gingery@informa.com

Executive Summary
O'Neill and Srinivasan head to Trump Tower, but Gottlieb has not been eliminated.
President-elect Donald Trump interviewed what appear to be two unconventional
candidates for FDA commissioner, but at least one other potential selection remains
among those that could receive the nomination.
The transition team indicated that Trump met with Jim O'Neill, managing director of
Mithril Capital Management, and Balaji Srinivasan, who is a founder of a direct-toconsumer genetic testing company, as well as a partner at Andreessen Horowitz and
CEO of 21.co, on Jan. 12 at Trump Tower in New York. Both have ties to Silicon
Valley billionaire Peter Thiel, who also was seen entering Trump Tower on that day,
according to press pool reports.
If O'Neill and Srinivasan are being considered for FDA commissioner, they would
represent a departure from the typical qualifications for the job, namely that the
commissioner be a physician.
O'Neill, who has held several positions at HHS in the past, already has been floated as
a potential commissioner candidate. Public statements indicate he prefers that FDA
allow marketing approval of products based only on their safety profile, without proof
of efficacy. (Also see "Possible Trump FDA Commish Candidate Favors (Much)
Lighter Touch" - Medtech Insight, 8 Dec, 2016.)